- Home
- ONBPO vs INM Comparison
ONBPO vs INM Comparison
Compare ONBPO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONBPO
- INM
- Stock Information
- Founded
- ONBPO N/A
- INM 1981
- Country
- ONBPO United States
- INM Canada
- Employees
- ONBPO 4028
- INM N/A
- Industry
- ONBPO Major Banks
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ONBPO Finance
- INM Health Care
- Exchange
- ONBPO Nasdaq
- INM Nasdaq
- Market Cap
- ONBPO N/A
- INM 3.2M
- IPO Year
- ONBPO N/A
- INM N/A
- Fundamental
- Price
- ONBPO $24.88
- INM $2.90
- Analyst Decision
- ONBPO
- INM
- Analyst Count
- ONBPO 0
- INM 0
- Target Price
- ONBPO N/A
- INM N/A
- AVG Volume (30 Days)
- ONBPO N/A
- INM 5.7M
- Earning Date
- ONBPO N/A
- INM 05-12-2025
- Dividend Yield
- ONBPO N/A
- INM N/A
- EPS Growth
- ONBPO N/A
- INM N/A
- EPS
- ONBPO N/A
- INM N/A
- Revenue
- ONBPO N/A
- INM $4,920,990.00
- Revenue This Year
- ONBPO N/A
- INM N/A
- Revenue Next Year
- ONBPO N/A
- INM N/A
- P/E Ratio
- ONBPO N/A
- INM N/A
- Revenue Growth
- ONBPO N/A
- INM N/A
- 52 Week Low
- ONBPO N/A
- INM $1.72
- 52 Week High
- ONBPO N/A
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ONBPO 52.49
- INM 50.30
- Support Level
- ONBPO $24.78
- INM $2.93
- Resistance Level
- ONBPO $25.09
- INM $5.50
- Average True Range (ATR)
- ONBPO 0.15
- INM 0.36
- MACD
- ONBPO 0.01
- INM 0.01
- Stochastic Oscillator
- ONBPO 46.39
- INM 22.22
About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.